Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 13263

1.

The cytotoxic mechanism of epigallocatechin gallate on proliferative HaCaT keratinocytes.

Chu YW, Liu ST, Yang YL, Huang SM, Wang WM.

J Biomed Sci. 2017 Aug 15;24(1):55. doi: 10.1186/s12929-017-0363-7.

PMID:
28810862
2.

HPV-11 variability, persistence and progression to genital warts in men: the HIM study.

Flores-Díaz E, Sereday KA, Ferreira S, Sirak B, Sobrinho JS, Baggio ML, Galan L, Silva RC, Lazcano-Ponce E, Giuliano AR, Villa LL, Sichero L, The Him Study Group.

J Gen Virol. 2017 Aug 15. doi: 10.1099/jgv.0.000896. [Epub ahead of print]

PMID:
28809141
4.

Molecular Screening and Single Nucleotide Polymorphism Typing of Molluscum Contagiosum Virus (MCV) from Genital Specimens, between 2012 and 2015

Taghinezhad-S S, Mohseni AH, Keyvani H, Ghobadi N.

Iran Biomed J. 2017 Aug 15. [Epub ahead of print]

PMID:
28806866
5.

Risk of cancer in patients with genital warts: A nationwide, population-based cohort study in Taiwan.

Cho CY, Lo YC, Hung MC, Lai CC, Chen CJ, Wu KG.

PLoS One. 2017 Aug 14;12(8):e0183183. doi: 10.1371/journal.pone.0183183. eCollection 2017.

6.

Lymphocyte profile and cytokine mRNA expression in peripheral blood mononuclear cells of patients with recurrent respiratory papillomatosis suggest dysregulated cytokine mRNA response and impaired cytotoxic capacity.

Holm A, Nagaeva O, Nagaev I, Loizou C, Laurell G, Mincheva-Nilsson L, Nylander K, Olofsson K.

Immun Inflamm Dis. 2017 Aug 14. doi: 10.1002/iid3.188. [Epub ahead of print]

7.

Progress in prophylactic human papillomavirus (HPV) vaccination in 2016: A literature review.

Maver PJ, Poljak M.

Vaccine. 2017 Aug 8. pii: S0264-410X(17)31064-2. doi: 10.1016/j.vaccine.2017.07.113. [Epub ahead of print]

PMID:
28801154
8.

The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review.

Graham SV.

Clin Sci (Lond). 2017 Aug 10;131(17):2201-2221. doi: 10.1042/CS20160786. Print 2017 Sep 1. Review.

PMID:
28798073
9.

Benign and malignant hybrid adnexal tumors in a patient with epidermodysplasia verruciformis.

Ho J, Kam SA, Al-Haseni A, Markova A, Sahni D, Lam C, Goldberg LJ, Bhawan J.

J Cutan Pathol. 2017 Aug 10. doi: 10.1111/cup.13022. [Epub ahead of print]

PMID:
28796338
10.

Nonavalent human papillomavirus vaccination as a treatment for warts in an immunosuppressed adult.

Ferguson SB, Gallo ES.

JAAD Case Rep. 2017 Jul 26;3(4):367-369. doi: 10.1016/j.jdcr.2017.05.007. eCollection 2017 Jul. No abstract available.

11.

Significance of interferon gamma in the prediction of successful therapy of common warts by intralesional injection of Candida antigen.

Nofal A, Marei A, Amer A, Amen H.

Int J Dermatol. 2017 Aug 8. doi: 10.1111/ijd.13709. [Epub ahead of print]

PMID:
28791682
12.

Targeted human papillomavirus vaccination for young men who have sex with men in Australia yields significant population benefits and is cost-effective.

Zhang L, Regan DG, Ong JJ, Gambhir M, Chow EPF, Zou H, Law M, Hocking J, Fairley CK.

Vaccine. 2017 Aug 5. pii: S0264-410X(17)31004-6. doi: 10.1016/j.vaccine.2017.07.078. [Epub ahead of print]

PMID:
28789853
13.

Antibody persistence and evidence of immune memory at 5years following administration of the 9-valent HPV vaccine.

Guevara A, Cabello R, Woelber L, Moreira ED Jr, Joura E, Reich O, Shields C, Ellison MC, Joshi A, Luxembourg A.

Vaccine. 2017 Aug 5. pii: S0264-410X(17)30913-1. doi: 10.1016/j.vaccine.2017.07.017. [Epub ahead of print]

PMID:
28789851
14.

Subungual Squamous Cell Carcinoma Associated with Long Standing Onychomycosis: Aggressive Surgical Approach with a Favourable Outcome.

Grigorov Y, Philipov S, Patterson J, Tchernev G, Gianfaldoni S, Lotti T, Wollina U.

Open Access Maced J Med Sci. 2017 Jul 21;5(4):480-482. doi: 10.3889/oamjms.2017.116. eCollection 2017 Jul 25.

15.

Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes.

Kalnin K, Chivukula S, Tibbitts T, Yan Y, Stegalkina S, Shen L, Cieszynski J, Costa V, Sabharwal R, Anderson SF, Christensen N, Jagu S, Roden RBS, Kleanthous H.

Vaccine. 2017 Aug 1. pii: S0264-410X(17)31012-5. doi: 10.1016/j.vaccine.2017.07.086. [Epub ahead of print]

16.

Preliminary study of analyzing mucosal human papillomaviruses in cutaneous warts by restriction fragment mass polymorphism.

Park SE, Ha JW, Kim CW, Kim SS.

J Dermatol. 2017 Aug 3. doi: 10.1111/1346-8138.13990. [Epub ahead of print]

PMID:
28771770
17.

Distinct clinico-immunological profile of patients infected with human papilloma virus genotypes 6 and 11.

Singh M, Thakral D, Kar HK, Rishi N, Sharma PK, Mitra DK.

Virusdisease. 2017 Jun;28(2):200-204. doi: 10.1007/s13337-017-0370-z. Epub 2017 May 20.

PMID:
28770246
18.

Functional characterization of CD4 and CD8 T cell responses among human papillomavirus infected patients with ano-genital warts.

Singh M, Thakral D, Rishi N, Kar HK, Mitra DK.

Virusdisease. 2017 Jun;28(2):133-140. doi: 10.1007/s13337-017-0382-8. Epub 2017 Jun 13.

PMID:
28770238
19.

CXCR4-specific Nanobodies as potential therapeutics for WHIM syndrome.

de Wit RH, Heukers R, Brink H, Arsova A, Maussang D, Cutolo P, Strubbe B, Vischer H, Bachelerie F, Smit MJ.

J Pharmacol Exp Ther. 2017 Aug 2. pii: jpet.117.242735. doi: 10.1124/jpet.117.242735. [Epub ahead of print]

20.

A Case of Eruptive Syringoma Mimicking Plane Warts.

Nair PA, Singhal RR, Gandhi SS.

Indian Dermatol Online J. 2017 Jul-Aug;8(4):284-286. doi: 10.4103/2229-5178.209603. No abstract available.

Supplemental Content

Loading ...
Support Center